Jump to content

Pages with the fewest revisions

Pharmacopedia
BrowseCategoriesLog in

Showing below up to 50 results in range #451 to #500.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Effect:Spontaneous bodily sensations (2 revisions)
  2. Problem:Cardiovascular risk reduction in type 2 diabetes (2 revisions)
  3. Montelukast (2 revisions)
  4. Effect:Euthymia (2 revisions)
  5. Effect:Delirium (2 revisions)
  6. Effect:Cognitive dysphoria (2 revisions)
  7. Effect:Dysarthria (2 revisions)
  8. Brimonidine (2 revisions)
  9. Effect:Empathy, affection and sociability enhancement (2 revisions)
  10. Effect:Palpitations (2 revisions)
  11. Phenotype:CYP2D6 normal metabolizer (2 revisions)
  12. Ticagrelor (2 revisions)
  13. Effect:Disinhibition (2 revisions)
  14. USLegal:DEA Schedule IV (2 revisions)
  15. Levofloxacin (2 revisions)
  16. Effect:Improved mood (2 revisions)
  17. Problem:Hypothyroidism (2 revisions)
  18. Effect:Color depression (2 revisions)
  19. Problem:COPD (2 revisions)
  20. Effect:Object activation (2 revisions)
  21. Problem:Binge-Eating Disorder (2 revisions)
  22. Nifedipine (2 revisions)
  23. Effect:Dream potentiation (2 revisions)
  24. Problem:Major Depressive Episode (2 revisions)
  25. Calcium (2 revisions)
  26. Effect:Analysis depression (2 revisions)
  27. Problem:Cognitive symptoms in chronic illness (2 revisions)
  28. Effect:Thought organization (2 revisions)
  29. Problem:Antisocial Personality Disorder (2 revisions)
  30. Effect:Simultaneous emotions (2 revisions)
  31. Problem:Smoking cessation (2 revisions)
  32. Sildenafil (2 revisions)
  33. Effect:Decreased appetite/Anorexia (2 revisions)
  34. Problem:Opioid overdose reversal (2 revisions)
  35. Valsartan (2 revisions)
  36. Effect:Multiple thought streams (2 revisions)
  37. Problem:Specific Learning Disorder with Dyscalculia (2 revisions)
  38. Ramipril (2 revisions)
  39. Effect:Suggestibility suppression (2 revisions)
  40. Problem:Weight loss (2 revisions)
  41. Problem:Attention Deficit Disorder (predominantly inattentive) (2 revisions)
  42. Effect:Visual processing acceleration (2 revisions)
  43. Effect:Tics (2 revisions)
  44. Flecainide (2 revisions)
  45. Effect:Vomiting (2 revisions)
  46. Effect:Delusion (2 revisions)
  47. Effect:Analysis enhancement (2 revisions)
  48. Effect:Mild euphoria (2 revisions)
  49. Phenotype:CYP2B6 ultrarapid metabolizer (2 revisions)
  50. Nystatin (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:FewestRevisions"